LCM
Lynx1 Capital Management Portfolio holdings
AUM
$346M
This Quarter Return
-3.35%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$117M
AUM Growth
+$117M
(+9%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
99.1%
Holding
15
New
1
Increased
9
Reduced
1
Closed
3
Top Buys
| 1 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$12.4M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$3.9M |
| 3 |
Immunic
IMUX
|
$3.83M |
| 4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$3.76M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$3.54M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$10.6M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$7.35M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$185K |
| 4 |
ELEV
Elevation Oncology
ELEV
|
$25K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLU
1
DELISTED
BELLUS Health Inc.
BLU
| $26.2M | 22.29% | 2,831,588 -20,000 | -0.7% | -$185K |
|
2
Merus
MRUS
$4.98B
| $22.7M | 19.31% | 1,001,217 +107,690 | +12% | +$2.44M |
|
|
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $21.1M | 17.99% | 1,674,677 +982,169 | +142% | +$12.4M |
|
|
ALPN
4
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $16.4M | 13.97% | 1,926,869 +442,176 | +30% | +$3.76M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $7.64M | 6.51% | 2,589,679 +1,201,174 | +87% | +$3.54M |
|
|
PRDS
6
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $6.69M | 5.7% | 2,180,560 +537,726 | +33% | +$1.65M |
|
|
PVLA
7
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $6.03M | 5.14% | 3,223,334 +2,087,015 | +184% | +$3.9M |
|
|
8
Immunic
IMUX
$80.9M
| $3.83M | 3.26% | +1,104,241 | New | +$3.83M |
|
|
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $2.99M | 2.55% | 191,565 +124,588 | +186% | +$1.95M |
|
|
THRX
10
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.79M | 2.38% | 504,862 +148,035 | +41% | +$819K |
|
11
Passage Bio
PASG
$22.7M
| $995K | 0.85% | 421,410 +315,906 | +299% | +$746K |
|
|
OTIC
12
DELISTED
Otonomy, Inc.
OTIC
| $62K | 0.05% | 30,000 | – | – |
|
|
ELEV
13
DELISTED
Elevation Oncology
ELEV
| – | – | -10,000 | Closed | -$25K |
|
|
14
Travere Therapeutics
TVTX
$1.56B
| – | – | -411,680 | Closed | -$10.6M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| – | – | -1,543,259 | Closed | -$7.35M |
|